Clarisse Audigier-Valette

Clarisse Audigier-Valette

UNVERIFIED PROFILE

Are you Clarisse Audigier-Valette?   Register this Author

Register author
Clarisse Audigier-Valette

Clarisse Audigier-Valette

Publications by authors named "Clarisse Audigier-Valette"

Are you Clarisse Audigier-Valette?   Register this Author

34Publications

1475Reads

11Profile Views

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial.

Clin Cancer Res 2019 Oct 7;25(19):5759-5765. Epub 2019 Jun 7.

Department of Thoracic Oncology, Centre d'investigation clinique Institut national de la santé et de la recherche médicale 1425, Hospital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris-Diderot University (Paris 7), Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2860DOI Listing
October 2019

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.

Eur J Cancer 2019 Jul 13;116:182-189. Epub 2019 Jun 13.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.019DOI Listing
July 2019

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

N Engl J Med 2018 May 16;378(22):2093-2104. Epub 2018 Apr 16.

From Memorial Sloan Kettering Cancer Center Hospital, New York (M.D.H.); Prof. Dr. Ion Chiricuta Institute of Oncology and Universitatea de Medicina si Farmacie Iuliu Hatieganu, Cluj-Napoca, Romania (T.-E.C.); Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland (A.P.); Seoul National University Bundang Hospital, Seoul, South Korea (J.S.L.); Ohio State University, Columbus (G.A.O.); Hôpital Sainte Musse, Toulon, France (C.A.-V.); Ospedale Santa Maria della Misericordia, Perugia, Italy (E.M.); First Department of Oncology, Metropolitan Hospital, Athens, Greece (H.L.); Antoni van Leeuwenhoek Ziekenhuis, Amsterdam (S.B.); Fundación Arturo López Pérez, Santiago, Chile (P.S.); Fox Chase Cancer Center, Philadelphia (H.B.); Winship Cancer Institute, Emory University, Atlanta (S.S.R.); Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.B.); LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany (M.R.); Princess Alexandra Hospital, Brisbane, QLD, Australia (K.J.O.); Bristol-Myers Squibb, Princeton, NJ (W.J.G., G.G., H.C., J.S., P.B., D.H., Y.F., F.N.); and Hospital Universitario 12 de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, and CiberOnc, Madrid (L.P.-A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1801946DOI Listing
May 2018

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

J Clin Oncol 2016 May 16;34(13):1476-83. Epub 2016 Feb 16.

Romain Corre and Hervé Léna, Centre Hospitalier Universitaire de Rennes, Rennes; Laurent Greillier, Université de Médecine, Marseille; Hervé Le Caër, Centre Hospitalier de Draguignan, Draguignan; Clarisse Audigier-Valette, Centre Hospitalier Intercommunal de Toulon; Henri Bérard, Hôpital Inter Armées Sainte-Anne, Toulon; Nathalie Baize, Centre Hospitalier Universitaire d'Angers, Angers; Lionel Falchero, Centre Hospitalier de Villefranche sur Saône, Villefranche sur Saône; Isabelle Monnet and Christos Chouaïd, Centre Hospitalier Intercommunal de Créteil, Créteil; Eric Dansin, Centre Oscar Lambret, Lille; Alain Vergnenègre, Centre Hospitalier Universitaire du Cluzeau, Limoges; Marie Marcq, Centre Hospitalier Départemental les Oudairies, La Roche-sur-Yon; Chantal Decroisette, Centre Hospitalier d'Annecy, Annecy; Jean-Bernard Auliac, Centre Hospitalier de Mantes La Jolie, Mantes la Jolie; Suzanna Bota, Centre Hospitalier Universitaire Charles Nicolle, Rouen; Régine Lamy, Centre Hospitalier de Bretagne Sud, Lorient; Cécile Dujon, Hôpital A. Mignot, Le Chesnay; Maurice Pérol, Centre Léon Bérard, Lyon; Jean-Pierre Daurès and Carine Plassot, Université Montpellier 1, Montpellier; Renaud Descourt, Centre Hospitalier Universitaire de Brest, Brest, France; and Bartomeu Massuti, Hospital General Universitario de Alicante, Alicante, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.5839DOI Listing
May 2016

Rapid clearance of circulating tumor DNA during treatment with AZD9291 of a lung cancer patient presenting the resistance EGFR T790M mutation.

Lung Cancer 2016 Jan 7;91:73-4. Epub 2015 Nov 7.

Laboratoire de Biochimie, Plateforme de Génétique Moléculaire des Cancers, CHU de Nantes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.11.008DOI Listing
January 2016

Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC.

Target Oncol 2015 Jun 15;10(2):247-53. Epub 2014 Aug 15.

Unité d'Oncologie Thoracique, PCMAC, CHU Grenoble France and INSERM U 823, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-014-0332-yDOI Listing
June 2015

ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?

Expert Rev Anticancer Ther 2015 Feb 21;15(2):225-33. Epub 2014 Nov 21.

Department of Respiratory Medicine and Thoracic Oncology, Hôpital Louis Pradel, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.2014.98
Publisher Site
http://dx.doi.org/10.1586/14737140.2014.986103DOI Listing
February 2015

Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units.

Intensive Care Med 2015 Jan 4;41(1):164-5. Epub 2014 Nov 4.

Grenoble University 1 U 823, A Bonniot Institute, J Fourier University, Rond-point de la Chantourne, 38706, La Tronche Cedex, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00134-014-3535-xDOI Listing
January 2015

[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?].

Bull Cancer 2014 Sep;101(9):823-31

AP-HP Marseille, Université Aix-Marseille, Service d'oncologie multidisciplinaire & innovations thérapeutiques, 13015 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1976DOI Listing
September 2014

The TAILOR study: to agree or to disagree?

Lung Cancer 2014 Jun 26;84(3):315-6. Epub 2014 Mar 26.

Medical Cancerology Department, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.03.019DOI Listing
June 2014

Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE.

J Clin Oncol 2014 Apr 17;32(12):1256-61. Epub 2014 Mar 17.

Marie Wislez and Jacques Cadranel, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris; Franck Morin, Intergroupe Francophone de Cancérologie Thoracique, Paris; Fabrice Barlesi, Aix Marseille University, Assistance Publique des Hôpitaux de Marseille; Anne Madroszyck, Institut Paoli Calmettes, Marseille; Benjamin Besse and Jean-Charles Soria, Institut Gustave Roussy, Villejuif; Julien Mazières, Hôpital Larrey, Toulouse; Patrick Merle, Centre Hospitalier Universitaire (CHU) de Clermont-Ferrand, Clermont-Ferrand; Clarisse Audigier-Valette, Hôpital Sainte Musse, Toulon; Denis Moro-Sibilot, CHU de Grenoble, Grenoble; Laure Gautier-Felizot, Centre Hospitalier de Dax, Dax; François Goupil, Centre Hospitalier du Mans, Le Mans; Aldo Renault, Centre Hospitalier de Pau, Pau; Elisabeth Quoix, Nouvel Hôpital Strasbourg, Strasbourg; Pierre-Jean Souquet, Centre Hospitalier Lyon-Sud; David Pérol, Centre Léon Bérard, Lyon; Romain Corre, Hôpital Pontchaillou, Rennes; and Gérard Zalcman, CHU Caen, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1525DOI Listing
April 2014

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.

Lung Cancer 2014 Feb 1;83(2):168-73. Epub 2013 Dec 1.

Département d'Anatomie et Cytologie Pathologiques, Pôle de Biologie et Pathologie, CHU Grenoble, France; Plateforme de Génétique Moléculaire des Tumeurs, Pôle de Biologie et Pathologie, CHU Grenoble, France; INSERM U 823-Institut A Bonniot-Université J Fourier, Grenoble, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.11.019DOI Listing
February 2014